+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Botanical Drug Market by Type, Source, Therapeutic Application, Formulation, End User, Route Of Administration - Global Forecast 2025-2030- Product Image
Botanical Drug Market by Type, Source, Therapeutic Application, Formulation, End User, Route Of Administration - Global Forecast 2025-2030- Product Image
Sale

Botanical Drug Market by Type, Source, Therapeutic Application, Formulation, End User, Route Of Administration - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6011074
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Botanical Drug Market grew from USD 3.75 billion in 2023 to USD 4.01 billion in 2024. It is expected to continue growing at a CAGR of 6.96%, reaching USD 6.01 billion by 2030.

The botanical drug market encompasses pharmaceuticals derived from plants and plant parts, designed for therapeutic use. These drugs are crucial due to growing consumer preference for natural products over synthetic ones, driven by perceived safety and fewer side effects. Their applications range from treating chronic conditions like cancer and diabetes to serving as adjunct therapies. The end-use scope primarily includes hospitals, clinics, and research institutes focusing on natural and holistic medical treatments. Key growth factors include increasing research investments, regulatory advancements such as easier FDA approvals for botanical drugs, and rising awareness about herbal medicines. The market also benefits from growing interests in alternative and complementary therapies, particularly in aging populations seeking holistic health solutions. Potential opportunities lie in expanding product lines targeting specific diseases and entering untapped markets in developing nations where traditional medicine holds significant cultural value. Innovations in extraction techniques, formulation technology, and clinical trials are recommended to enhance efficacy and safety profiles of botanical drugs, aligning with consumer demand for transparency and sustainability. Despite its potential, the market faces limitations such as limited clinical trial data and standardization issues. Challenges include competition from conventional pharmaceuticals, stringent regulatory environments, and high R&D costs. Moreover, knowledge gaps regarding the pharmacokinetic properties of botanical compounds hinder broader adoption. To navigate these challenges, businesses should invest in comprehensive clinical research, collaborations with academic entities, and advocacy for regulatory reforms to support botanical drug evaluations. Innovation areas include exploring synergistic effects of combined botanicals and adopting precision medicine approaches tailored to genetic profiles. The market's nature is characterized by rapid evolution with emerging companies competing alongside established pharmaceutical firms, driving increased focus on personalized medicine and innovative delivery systems for enhanced patient adherence and outcomes.

Understanding Market Dynamics in the Botanical Drug Market

The Botanical Drug Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Government initiatives and funding supporting the development of botanical drugs
    • Expansion of distribution channels and e-commerce platforms for botanical products
    • Adoption of advanced extraction and formulation technologies in botanical drug manufacturing
    • Significant investments by key market players in botanical drug research and commercialization
  • Market Restraints
    • Limited clinical trial data and scientific validation on the efficacy and safety of botanical drugs
    • Intellectual property challenges and competition with synthetic drugs impede market growth
  • Market Opportunities
    • Rising prevalence of chronic diseases increasing the adoption of botanical drugs for alternative treatment
    • Expansion of distribution channels including e-commerce platforms boosting market reach and accessibility
    • Development of personalized botanical medicine catering to individual health needs and preferences driving market growth
  • Market Challenges
    • Limited scientific evidence and clinical trials to support botanical drug efficacy and safety claims hamper market growth
    • Supply chain disruptions and raw material scarcity affect production consistency in the botanical drug industry

Exploring Porter’s Five Forces for the Botanical Drug Market

Porter’s Five Forces framework further strengthens the insights of the Botanical Drug Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Botanical Drug Market

External macro-environmental factors deeply influence the performance of the Botanical Drug Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Botanical Drug Market

The Botanical Drug Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Botanical Drug Market

The Botanical Drug Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Botanical Drug Market

The Botanical Drug Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Botanical Drug Market, highlighting leading vendors and their innovative profiles. These include Aphios Corporation, Botanix Pharmaceuticals Ltd, CanniMed Therapeutics Inc., Cardiol Therapeutics Inc., CV Sciences, Inc., Ecofibre Limited, EcoGen Laboratories, Emerald Health Pharmaceuticals, GB Sciences, Inc., GW Pharmaceuticals plc, HempMeds, InMed Pharmaceuticals Inc., Jazz Pharmaceuticals plc, Lexaria Bioscience Corp., MediPharm Labs Corp., PhytoTech Therapeutics Ltd., Tetra Bio-Pharma Inc., Tikun Olam Ltd., Veritas Pharma Inc., and Zynerba Pharmaceuticals, Inc..

Market Segmentation & Coverage

This research report categorizes the Botanical Drug Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Herbal Drugs
      • Multiple Herb Drugs
      • Single Herb Drugs
    • Nutraceuticals
    • Phytomedicines
  • Source
    • Algae
    • Fungi
    • Plants
      • Barks
      • Leaves
      • Roots
      • Seeds
  • Therapeutic Application
    • Cancer
    • Cardiovascular Diseases
    • Diabetes
    • Digestive Disorders
    • Respiratory Disorders
  • Formulation
    • Capsules
    • Extracts
    • Ointments
    • Powders
    • Tablets
  • End User
    • Clinics
    • Homecare
    • Hospitals
  • Route Of Administration
    • Injectable
    • Oral
    • Topical
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Government initiatives and funding supporting the development of botanical drugs
5.1.1.2. Expansion of distribution channels and e-commerce platforms for botanical products
5.1.1.3. Adoption of advanced extraction and formulation technologies in botanical drug manufacturing
5.1.1.4. Significant investments by key market players in botanical drug research and commercialization
5.1.2. Restraints
5.1.2.1. Limited clinical trial data and scientific validation on the efficacy and safety of botanical drugs
5.1.2.2. Intellectual property challenges and competition with synthetic drugs impede market growth
5.1.3. Opportunities
5.1.3.1. Rising prevalence of chronic diseases increasing the adoption of botanical drugs for alternative treatment
5.1.3.2. Expansion of distribution channels including e-commerce platforms boosting market reach and accessibility
5.1.3.3. Development of personalized botanical medicine catering to individual health needs and preferences driving market growth
5.1.4. Challenges
5.1.4.1. Limited scientific evidence and clinical trials to support botanical drug efficacy and safety claims hamper market growth
5.1.4.2. Supply chain disruptions and raw material scarcity affect production consistency in the botanical drug industry
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Botanical Drug Market, by Type
6.1. Introduction
6.2. Herbal Drugs
6.2.1. Multiple Herb Drugs
6.2.2. Single Herb Drugs
6.3. Nutraceuticals
6.4. Phytomedicines
7. Botanical Drug Market, by Source
7.1. Introduction
7.2. Algae
7.3. Fungi
7.4. Plants
7.4.1. Barks
7.4.2. Leaves
7.4.3. Roots
7.4.4. Seeds
8. Botanical Drug Market, by Therapeutic Application
8.1. Introduction
8.2. Cancer
8.3. Cardiovascular Diseases
8.4. Diabetes
8.5. Digestive Disorders
8.6. Respiratory Disorders
9. Botanical Drug Market, by Formulation
9.1. Introduction
9.2. Capsules
9.3. Extracts
9.4. Ointments
9.5. Powders
9.6. Tablets
10. Botanical Drug Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Homecare
10.4. Hospitals
11. Botanical Drug Market, by Route Of Administration
11.1. Introduction
11.2. Injectable
11.3. Oral
11.4. Topical
12. Americas Botanical Drug Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Botanical Drug Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Botanical Drug Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
15.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. BOTANICAL DRUG MARKET RESEARCH PROCESS
FIGURE 2. BOTANICAL DRUG MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BOTANICAL DRUG MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BOTANICAL DRUG MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BOTANICAL DRUG MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BOTANICAL DRUG MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL BOTANICAL DRUG MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 15. GLOBAL BOTANICAL DRUG MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 17. GLOBAL BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. AMERICAS BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. AMERICAS BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 21. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. BOTANICAL DRUG MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 27. BOTANICAL DRUG MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. BOTANICAL DRUG MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BOTANICAL DRUG MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BOTANICAL DRUG MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BOTANICAL DRUG MARKET DYNAMICS
TABLE 7. GLOBAL BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BOTANICAL DRUG MARKET SIZE, BY MULTIPLE HERB DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BOTANICAL DRUG MARKET SIZE, BY SINGLE HERB DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BOTANICAL DRUG MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BOTANICAL DRUG MARKET SIZE, BY PHYTOMEDICINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BOTANICAL DRUG MARKET SIZE, BY ALGAE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BOTANICAL DRUG MARKET SIZE, BY FUNGI, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BOTANICAL DRUG MARKET SIZE, BY PLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BOTANICAL DRUG MARKET SIZE, BY BARKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BOTANICAL DRUG MARKET SIZE, BY LEAVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BOTANICAL DRUG MARKET SIZE, BY ROOTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BOTANICAL DRUG MARKET SIZE, BY SEEDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BOTANICAL DRUG MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BOTANICAL DRUG MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BOTANICAL DRUG MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BOTANICAL DRUG MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BOTANICAL DRUG MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BOTANICAL DRUG MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BOTANICAL DRUG MARKET SIZE, BY EXTRACTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BOTANICAL DRUG MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BOTANICAL DRUG MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BOTANICAL DRUG MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BOTANICAL DRUG MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BOTANICAL DRUG MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BOTANICAL DRUG MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BOTANICAL DRUG MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BOTANICAL DRUG MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BOTANICAL DRUG MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 68. CANADA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. CANADA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 70. CANADA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 71. CANADA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 72. CANADA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. CANADA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 74. CANADA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. CANADA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 76. MEXICO BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. MEXICO BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 78. MEXICO BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 79. MEXICO BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 80. MEXICO BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. MEXICO BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 82. MEXICO BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. MEXICO BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 104. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 105. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 106. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 108. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 110. CHINA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. CHINA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 112. CHINA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 113. CHINA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 114. CHINA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. CHINA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 116. CHINA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. CHINA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 118. INDIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. INDIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 120. INDIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 121. INDIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 122. INDIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. INDIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 124. INDIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. INDIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 126. INDONESIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. INDONESIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 128. INDONESIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 129. INDONESIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 130. INDONESIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. INDONESIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 132. INDONESIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. INDONESIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 134. JAPAN BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. JAPAN BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 136. JAPAN BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 137. JAPAN BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 138. JAPAN BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. JAPAN BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 140. JAPAN BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. JAPAN BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 142. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 144. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 145. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 146. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 148. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 150. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 151. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 152. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 153. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 154. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 156. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 158. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 159. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 160. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 161. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 162. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 164. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 166. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 168. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 169. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 170. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 172. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 174. TAIWAN BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 175. TAIWAN BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 176. TAIWAN BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 177. TAIWAN BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 178. TAIWAN BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. TAIWAN BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 180. TAIWAN BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. TAIWAN BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 182. THAILAND BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 183. THAILAND BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 184. THAILAND BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 185. THAILAND BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 186. THAILAND BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. THAILAND BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 188. THAILAND BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. THAILAND BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 190. VIETNAM BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 191. VIETNAM BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 192. VIETNAM BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 193. VIETNAM BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 194. VIETNAM BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. VIETNAM BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 196. VIETNAM BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. VIETNAM BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 207. DENMARK BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 208. DENMARK BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 209. DENMARK BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 210. DENMARK BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 211. DENMARK BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. DENMARK BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 213. DENMARK BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. DENMARK BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 215. EGYPT BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 216. EGYPT BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 217. EGYPT BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 218. EGYPT BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 219. EGYPT BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. EGYPT BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 221. EGYPT BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. EGYPT BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 223. FINLAND BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 224. FINLAND BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 225. FINLAND BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 226. FINLAND BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 227. FINLAND BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. FINLAND BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 229. FINLAND BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. FINLAND BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 231. FRANCE BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 232. FRANCE BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 233. FRANCE BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 234. FRANCE BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 235. FRANCE BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. FRANCE BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 237. FRANCE BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. FRANCE BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 239. GERMANY BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 240. GERMANY BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 241. GERMANY BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 242. GERMANY BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 243. GERMANY BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. GERMANY BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 245. GERMANY BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. GERMANY BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 247. ISRAEL BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 248. ISRAEL BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 249. ISRAEL BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 250. ISRAEL BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 251. ISRAEL BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. ISRAEL BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 253. ISRAEL BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. ISRAEL BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 255. ITALY BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 256. ITALY BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 257. ITALY BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 258. ITALY BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 259. ITALY BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. ITALY BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 261. ITALY BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. ITALY BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 269. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 271. NIGERIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 272. NIGERIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 273. NIGERIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 274. NIGERIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 275. NIGERIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. NIGERIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 277. NIGERIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. NIGERIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 279. NORWAY BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 280. NORWAY BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 281. NORWAY BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 282. NORWAY BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 283. NORWAY BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. NORWAY BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 285. NORWAY BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 286. NORWAY BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 287. POLAND BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 288. POLAND BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 289. POLAND BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 290. POLAND BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 291. POLAND BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. POLAND BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 293. POLAND BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. POLAND BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 295. QATAR BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 296. QATAR BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 297. QATAR BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 298. QATAR BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 299. QATAR BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. QATAR BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 301. QATAR BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. QATAR BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 303. RUSSIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 304. RUSSIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 305. RUSSIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 306. RUSSIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 307. RUSSIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 308. RUSSIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 309. RUSSIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. RUSSIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 312. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 314. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 316. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 318. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 320. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 322. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 324. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 326. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 327. SPAIN BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 328. SPAIN BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 329. SPAIN BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 330. SPAIN BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 331. SPAIN BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 332. SPAIN BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 333. SPAIN BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 334. SPAIN BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 335. SWEDEN BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 336. SWEDEN BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 337. SWEDEN BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 338. SWEDEN BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 339. SWEDEN BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 340. SWEDEN BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 341. SWEDEN BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 342. SWEDEN BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 343. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 344. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 345. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 346. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 347. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 348. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 349. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 350. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 351. TURKEY BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 352. TURKEY BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 353. TURKEY BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 354. TURKEY BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 355. TURKEY BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 356. TURKEY BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 357. TURKEY BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 358. TURKEY BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 359. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 360. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 361. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 362. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
TABLE 363. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 364. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 365. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 366. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 367. UNITED KINGDOM BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 368. UNITED KINGDOM BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
TABLE 369. UNITED KINGDOM BOTANICAL DRUG MARKET SIZE, BY SOURCE, 201

Companies Mentioned

The leading players in the Botanical Drug market, which are profiled in this report, include:
  • Aphios Corporation
  • Botanix Pharmaceuticals Ltd
  • CanniMed Therapeutics Inc.
  • Cardiol Therapeutics Inc.
  • CV Sciences, Inc.
  • Ecofibre Limited
  • EcoGen Laboratories
  • Emerald Health Pharmaceuticals
  • GB Sciences, Inc.
  • GW Pharmaceuticals plc
  • HempMeds
  • InMed Pharmaceuticals Inc.
  • Jazz Pharmaceuticals plc
  • Lexaria Bioscience Corp.
  • MediPharm Labs Corp.
  • PhytoTech Therapeutics Ltd.
  • Tetra Bio-Pharma Inc.
  • Tikun Olam Ltd.
  • Veritas Pharma Inc.
  • Zynerba Pharmaceuticals, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages191
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 4.01 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.01 Billion
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Botanical & Plant Derived Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Botanical & Plant Derived Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 77 Pages
  • Global
From
Botanical and Plant-Derived Drugs Market 2024-2028 - Product Image

Botanical and Plant-Derived Drugs Market 2024-2028

  • Report
  • 177 Pages
  • Global
From
Global Perspectives on Astaxanthin - Product Image

Global Perspectives on Astaxanthin

  • Book
  • 824 Pages
  • Global
Phytochemical Profiling of Commercially Important South African Plants - Product Image

Phytochemical Profiling of Commercially Important South African Plants

  • Book
  • 275 Pages
  • South Africa
Pharmacognostical Assessment of Novel Potential Medicinal Plants - Product Image

Pharmacognostical Assessment of Novel Potential Medicinal Plants

  • Book
Copyright © 2002-2024 Research and Markets. All Rights Reserved.